Founded in 1971, and with 700 members worldwide, the British Society for Antimicrobial Chemotherapy exists to facilitate the acquisition and dissemination of knowledge in the field of antimicrobial chemotherapy.
At the forefront of the antimicrobial chemotherapy field, the Society meets its aims by setting standards for antimicrobial susceptibility testing and use, both within the UK and overseas, supporting microbiologists in their practice, and the promotion and provision of channels through which its Members can ensure their continuing professional development.
The BSAC publishes the Journal of Antimicrobial Chemotherapy (JAC), which is one of the leading journals in the field and is internationally renowned for its scientific excellence.
The Society collaborates with relevant bodies, both nationally and internationally, and currently leads national programmes of surveillance and susceptibility testing to determine the effectiveness of antimicrobial and chemotherapeutic agents.
Through a series of educational and other initiatives, the Society offers advice to government, its membership, the wider medical profession and the public on issues relating to antimicrobial agents, the appropriate and prudent use of antibiotics, and the management of community and hospital-acquired infection(s). In addition, scientific excellence is promoted through the awarding of grants for research.